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Background: Cholesterol crystals are often seen abundantly within atheromatous
plaques and at sites of plaque disruption. Recent studies have demonstrated that
crystallization of cholesterol promotes volume expansion potentially, triggering plaque
rupture. However, the relationship between cholesterol crystals and other features of
plaque vulnerability has not been characterized. As optical coherence tomography (OCT)
enables the visualization of cholesterol crystals in vivo, we investigated the impact of
cholesterol crystals on plaque vulnerability by using OCT.
Methods: 102 patients with angiographic coronary artery disease underwent OCT
imaging of non-culprit lipid plaque. Cholesterol crystals were identified as a thin, linear
region with high signal intensity and backscattering. Patients with (n44) and without
(n58) cholesterol crystals were compared with regard to clinical characteristics and
OCT-derived features of plaque vulnerability.
Results: 43% of study population demonstrated cholesterol crystals in non-culprit
atherosclerotic plaque. Patients with cholesterol crystals were more likely to have a history
of myocardial infarction (41% vs. 22%, p0.04) and demonstrated higher leukocyte
counts (9362 /ul vs. 7911 /ul, p0.03). These patients more frequently received ACE-I
(64% vs. 38%, p0.009) and were less likely to be treated with a statin (52% vs. 32%,
p0.04). OCT demonstrated that patients with cholesterol crystals had a thinner fibrous
cap thickness and were more likely to contain plaque microchannels and lipid pools
(Table).
Conclusions: The presence of cholesterol crystals is associated with features of plaque
vulnerability on OCT. These patients require more intensive risk factor modification for








myocardial infarction 41% 22% 0.04
ACE-I 38% 64% 0.01
Statins 52% 32% 0.04
Leukocyte /ul 7911 2585 9362 4309 0.03
FCT 98.6 62.0 um 71.9 25.8 um 0.03




TCFA 41% 58% 0.10
FCT  fibrous cap thickness, TCFA  thin-cap fibroatheroma.
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Background: The Combo Dual Therapy Stent (OrbusNeich Medical, Ft. Lauderdale,
FL, USA) combines low-dose sirolimus delivery from an abluminal biodegradable
polymer matrix along with a covalently bound anti-CD34 antibody layer in a combination
device designed for control of neointimal proliferation as well as to promote vessel
healing by stimulating endothelial repair. Optical coherence tomography (OCT) provides
important insight into morphology and mechanisms of vessel healing associated with the
implantation of intracoronary stents.
Methods: REMEDEE OCT (NCT01405287) is designed to assess the early vascular
healing of the Combo stent as compared to an everolimus eluting stent (EES) in patients
with Acute Coronary Syndrome (ACS: STEMI & non-STEMI) requiring treatment of
single, de novo native coronary artery lesions. REMEDEE OCT is a prospective,
multicenter, randomized study designed to enroll 60 ACS patients, randomized 1:1 to be
treated with the Combo stent versus an EES (XIENCE V, Abbott Vascular, Illinois USA
or PROMUS, Boston Scientific, Natick, MA, USA). All patients receive OCT and QCA
follow-up imaging at 60 days post procedure and clinical follow-up at 30, 60, 180, 360
and 540 days. QCA and OCT was performed at baseline and a subset of patients received
IVUS and assessment of circulating EPCs. The primary study endpoint is the OCT
assessment of the percentage of uncovered struts per stent at 60 days of the Combo stent
compared to its control. Secondary endpoints include OCT assessment of indices of
neointimal heterogeneity (optical density analysis), and clustering of uncovered and/or
malapposed struts. All OCT, QCA, EPC and IVUS data are measured and assessed by
independent Core Laboratories. Secondary clinical endpoints will also be reported.
Results: 60 subjects were consented and randomized in a 1:1 fashion at 6 investigative
sites in Europe.
Conclusions: The Combo Dual Therapy Stent is a new technology unique in its
combined mechanism of action. The REMEDEE OCT 60-day stent strut healing results
will be the first RCT evaluation of the effectiveness of the Combo Stent to influence
vascular healing.
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Background: Patients with diabetes mellitus have increased risk of in-stent restenosis
after coronary stent implantation due to intimal hyperplasia (IH). The aim of this study
(substudy of the SORT OUT IV trial), was to use volumetric intravascular ultrasound
(IVUS) to evaluate the effects of the everolimus-eluting Xience™/Promus™ stent (EES)
and the sirolimus-eluting Cypher™ stent (SES) on intima hyperplasia in diabetic patients.
Methods: In the DiabeDES IV IVUS trial, serial IVUS 10-month follow-up data were
available in 88 patients, including 48 EES and 40 SES treated patients. IVUS of the
stented segment and 5-mm long segments immediately proximal and distal to the stent
was performed after the procedure and at follow-up. IVUS endpoints included IH volume
and in-stent percent volume obstruction.
Results: Baseline clinical characteristics and lesion parameters were similar in the two
groups. As compared to the SES group, IH volume was increased in the EES group
[median (interquartile range): 2.8 mm3 (0.0 to 12.6) vs. 0.0 mm3 (0.0 to 1.1), p0.001].
In-stent % volume obstruction was increased in EES as compared to SES [median
(interquartile range): 1.6% (0.0 – 8.2) vs. 0.0% (0.0 – 1.0), p0.001]. Peri-stent external
elastic membrane (EEM) volume: (post procedure vs. follow-up EES [300 mm3
(219-491) vs. 307 mm3 (223-482); pns] and SES [316 mm3 (235-399) vs. 323 mm3
(246-404); pns]) and peri-stent plaque volume: EES [163 mm3 (103-273) vs. 184
mm3 (115-291); pns] and SES [186 mm3 (139-248) vs. 175 mm3 (153-243); pns])
were unchanged in both groups. In the distal reference and proximal reference, there were
no significant changes in reference-segment EEM, plaque or lumen volume in either of the
two stent groups.
Conclusions: In diabetic patients, EES stent implantation was associated with increased
IH volume obstruction compared to SES stent without involvement of vascular remod-
eling.
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Background: Also there are differences in the carotid and coronary vasculature, both
vascular distributions are believed to share common pathway in disease progression.
However, little is known about atherosclerotic plaque composition and morphological
differences between carotid and coronary artery disease. The aim of the study was to
determine correlation between intravascular ultrasound virtual histology (IVUS-VH)
defined atherosclerotic plaque components in coronary and carotid artery atherosclerotic
lesions.
Methods: In a single-center prospective study 100 consecutive patients (60 men and 40
women) with mean age 69.618.44 years were enrolled. All patients were scheduled for
carotid and/or coronary artery stenting and underwent IVUS-VH examination of coronary
and carotid plaque before intervention. Statistical comparison between coronary and
carotid artery plaque composition according to IVUS-VH was done with Pearson
correlation.
Results: High percentage of necrotic core was found both in coronary (22.557.30) and
carotid (19.849.35) artery plaques, r0.459, p0.001. Percentage of dense calcium
(13.588.15 vs. 7.675.64, r0.557, p0.001), fibrolipids (12.549.08 vs.
19.559.96, r0.379, p0.001) and fibrotic tissue (51.7210.33 vs. 53.427.95,
r0.422, p0.001) showed moderate, statistically significant correlation between coro-
nary and carotid arteries, respectively (Figure 1).
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Conclusions: We found significant correlations of IVUS-VH determined atherosclerotic
plaque components between coronary and carotid arteries in patients with atherosclerosis
involving both arterial beds.
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Background: The frequency, type and extent of neoatherosclerosis within drug-eluting
stents (DES) has not been described during very long-term follow-up. Moreover, it is
unknown whether DES eluting sirolimus differ from those eluting paclitaxel in the
propensity for neoatherosclerosis during long-term follow-up.
Methods: The SIRTAX LATE OCT population was analyzed for evidence of neoath-
erosclerosis within stented segments five years after DES implantation. Using OCT
definitions according to the Consensus Statement of the International Working Group of
OCT, we assessed the presence of fibrocalcific plaques, fibroatheromas, macrophage
accumulations, microvessels, as well as surface erosions and ruptures in each single
frame. Plaques were considered to be present in case of a longitudinal extension of at least
1mm, and all other findings had to be visualized in at least three consecutive frames.
Results: All segments were independently assessed by two experienced observers. A
total of 89 event-free patients with 41 lesions treated with SES (41 patients) and 48 lesions
treated with PES (48 patients) were analysed at five years of follow-up. Neoatheroscle-
rotic plaques were observed in 15% of lesions, and fibroatheromas (12.4%) were more
common than fibrocalcific plaques (5.6%). While macrophage accumulations were
frequently present (32.6%), microvessels (2.2%) and surface erosions (2.2%) were rare,
and no plaque rupture was observed. Neoatherosclerotic plaques were more common
among lesions treated with PES (25%) than SES (5%; P 0.01), and differences between
stent types applied to both the frequency of fibrocalcific plaques (SES 0%, PES 10.5%,
p0.041) as well as fibroatheromas (SES 4.9% vs. PES 18.8%, p0.046). Similarly,
macrophage accumulations were more frequent among lesions treated with PES (47.9%)
than SES (14.6%, p0.001).
Conclusions: Among event-free patients, neoatherosclerotic plaques were observed in
15% of lesions five years after DES implantation. The frequency, type and extent of
neoatherosclerotic changes were importantly influenced by the implanted DES type.
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Background: Cavity aperture resulting from plaque rupture is often located in the
proximal for STEMI patients and distal for NSTEMI patients. To investigate the
characteristics of lesions avoiding onset of AMI through observing lesion cavities in
angina pectoris patients.
Methods: Target population consisted of 232 patients (250 lesions) with ischemic heart
disease (excluding AMI patients) undergoing OCT prior to therapeutic treatment that
presented to our facility from May, 2009 to December, 2011. Of these, OCT findings
determined a cavity at stenosed location in 22 patients. A comparative investigation was
performed on cavity aperture location: proximal side (Group P: 12 lesions); others (group
D: 8 lesions).
Results: OCT findings Distal lumen area (group P: 5.971.88, group D: 8.682.51,
p0.05), minimal lumen area (1.951.21, 2.681.31), cavity area (1.871.28,
3.091.02, p0.05), proximal lumen area (6.762.24, 10.723.74, p0.05) Location of
plaque rupture site was: proximal (group P: 66%, group D: 38%); middle (25%, 12%);
distal (9%, 50%, p0.05). There was no difference determined between groups for
location of MLA or residual low intensity area. Furthermore, there was a higher tendency
for group D to have spotty calcification at lesion location compared to Group P (50%,
88%, respectively).
Conclusions: In comparison to those patients with proximal cavity aperture, distal cavity
aperture patients had larger vessel diameter, larger plaque volume and plaque disruption




Impact of the Prevalence of Diabetes Mellitus on Coronary Plaque
Vulnerability Assessed by Integrated Backscatter Intravascular Ultrasound
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Background: Diabetes mellitus (DM) is a well-established risk factor for coronary artery
disease (CAD). However, little is known about relationship the prevalence of DM and
coronary plaque vulnerability assessed by integrated backscatter intravascular ultrasound
(IB-IVUS).
Methods: One hundred sixteen consecutive patients with stable CAD who underwent
percutaneous coronary intervention were enrolled. Nonculprit coronary lesions with mild
to moderate stenosis were measured by IB-IVUS. A total of 20 IB-IVUS images were
recorded at an interval of 0.5 mm for 10 mm length in each plaque. Patients were divided
into two groups: the DM group and the non-DM group. We assessed the relations among
DM and coronary plaque instability using IB-IVUS.
Results: Plaque volume (PV) and percentage of PV (%PV, 100PV/Vessel Volume) in
the DM group were significantly higher than those in the non-DM group (66.022.7 mm3
vs. 56.821.2 mm3, P0.0278 and 42.59.7% vs. 39.08.8%, P0.0453, respectively).
Lipid volume (LV) and percentage of LV (%LV, 100LV/PV) in the DM group were
significantly higher than those in the non-DM group (28.915.5 mm3 vs. 22.213.0
mm3, P0.0130 and 42.112.4% vs. 37.312.2%, P0.0409, respectively). Further-
more, multiple regression analysis revealed that the prevalence of DM was independently
associated with PV (p0.0351), LV (p0.0164) and %LV (p0.0304) among IVUS
parameters in addition to other metabolic factors.
Conclusions: Nonculprit coronary lesions in patients with DM are associated with more
lipid-rich plaque content and a greater PV, suggesting that DM patients increased plaque
vulnerability.
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Clinical Feasibility of Higher-Frequency IVUS for Quantitative Measurements
of Native Coronary Lesions: First-in-Human Experience with 60MHz versus
40MHz IVUS Imaging
Ching-Chang Huang1, Kenji Sakamoto1, Kaori Nakagawa1, Paul Yock1,
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Background: Despite the technical advantage of improved image resolutions, higher-
frequency IVUS imaging may theoretically be susceptible to impaired lumen and vessel
border detection due to higher blood scattering and lower signal penetration within the
tissue. This first-in-human study aimed to evaluate the feasibility of 60MHz IVUS
imaging with a novel multi-frequency IVUS system in in-vivo quantitative assessment of
native coronary lesions.
Methods: A total of 121 matched cross-sections were imaged and compared at 40MHz
and 60MHz. Visibilities of lumen and vessel borders were classified into 3 grades (good:
entire circumference visible, fair: 75% visible, and poor: 75% visible). Quantitative
evaluation included area and minimum diameter measurements of lumen (LA; MLD) and
vessel (VA; MVD).
Results: Good visualization of lumen border was achieved in 87.6% with 60MHz
compared to 79.3% with 40MHz (p0.08), while the rates of good vessel border
detection were similar between the 2 frequency imagings (p0.79). Overall, the 40MHz
and 60MHz imagings showed comparable visibilities of lumen and vessel borders. All
quantitative measurements significantly correlated with good agreements (LA: r20.97;
MLD: r20.95; VA: r20.97; MVD: r20.93, p0.001 for all) between the 2 frequency
imagings.
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AMwww.jacc.tctabstracts2012.com
JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Imaging B81
P
O
ST
E
R
S
